UFT, a compound containing uracil and tegafur (a prodrug of 5-fluorouracil) in a 4:1 molar ratio, has been used in Japan for the treatment of and as adjuvant chemotherapy for bladder cancer. In phase II studies, 300 to 600
Yoshinobu Kubota, MD, PhD
Advertisement
Articles by Yoshinobu Kubota, MD, PhD
Advertisement
Latest Updated Articles
- UFT in Bladder Cancer
Published: July 1st 1999 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Cancer Vaccine/Pembrolizumab Improves PFS in Treatment-Naive Melanoma
2
Relacorilant Regimen Improves PFS in Platinum-Resistant Ovarian Cancer
3
Sacituzumab Tirumotecan Improves Survival in Second-Line EGFR+ NSCLC
4
FDA Issues CRL for Dasatinib in CML/ALL
5
